Summit Pharmacy Pty Ltd
Paid four TGA infringement notices totalling A$75,120 over alleged bulk manufacturing of medicinal cannabis oils
This entry is about Australia — not the country you picked in the header.
According to Therapeutic Goods Administration, Apr 14, 2025 · Read the source · +1 more
- Where
- Queensland, Australia
- Last checked
Summary
The Therapeutic Goods Administration (TGA) said on 14 April 2025 that it had issued four infringement notices totalling A$75,120 to Queensland-based Summit Pharmacy Pty Ltd for the alleged unlawful manufacturing of medicinal cannabis products. The pharmacy paid all four notices in February 2025, according to the TGA.
The notices followed an inspection by the TGA and Queensland Health in August 2024, which the TGA says found the pharmacy manufacturing medicinal cannabis oils in bulk amounts. The TGA notes that the Therapeutic Goods Act 1989 prohibits manufacturing therapeutic goods unless they are on the ARTG or covered by an exemption, approval or authority, and that pharmacies compounding medicinal cannabis must meet all regulatory requirements first. Payment of an infringement notice is not an admission of liability.
What the source found
- Joint TGA and Queensland Health inspection in August 2024
- Inspection allegedly found medicinal cannabis oils being manufactured in bulk
- Four infringement notices totalling A$75,120, paid in February 2025
- Alleged contravention: section 19D(1) of the Therapeutic Goods Act 1989, per the TGA infringement notice register
Products named
- medicinal cannabis oils (compounded)
Timeline
TGA and Queensland Health inspect the pharmacy
Four infringement notices paid
TGA publishes the infringement notices
Sources
- Regulator
Therapeutic Goods Administration · Apr 14, 2025
Summit Pharmacy Pty Ltd issued infringement notices for the alleged unlawful manufacturing of medicinal cannabis products - Regulator
Therapeutic Goods Administration · Sep 18, 2026
Infringement notices
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
Manufacturing (not advertising) breach. Pharmacy location within Queensland not stated by the TGA. Paid; no further action known.
Comments
No comments yet.
Related entries
The full Red ListSouthern Stars Inc
Southern Stars Inc
Southern Stars Inc penalised $5,000 by Health Canada for missing its 2024 key investors report
Starrpac Industries Ltd
Starrpac Industries Ltd
Starrpac Industries Ltd penalised $5,000 by Health Canada for missing its 2024 key investors report
925 Market INC
925 Market INC
NYC Sheriff summons for a cannabis violation by a place of business
Tell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.